OBJECTIVE To select the coating fluid prescription of nefopam controlled release pellets.
目的筛选平痛新控释微丸包衣液处方。
Objective: to investigate the factors involved in the release in vitro degree of terbutaline sulphate pulsatile controlled release pellets.
目的考察硫酸特布他林脉冲控释微丸释放度的影响因素。
Methods Membrane controlled-release technique and centrifugal coating pelletization were used to prepare sinomenine hydrochloride controlled release pellets.
方法采用膜控技术，离心造粒法制备盐酸青藤碱控释微丸。
By using membrane controlled-release technique and centrifugal coating pelletization, sinomenine hydrochloride controlled-release pellets were prepared.
采用膜控技术，离心包衣造粒法制备了盐酸青藤碱控释微丸。
The timed release pellets consist of 5 laminar layers from the center to the outside :the core, the drug layer, the swelling agent layer , the block layer and the controlled layer .
该脉冲微丸由5层结构组成，从内而外分别是丸芯、药物层、溶胀层、阻滞层和水不溶性控释层。
Conclusions The glipizide film-controlled sustained-release pellets were successfully prepared and the in-vitro drug release conformed to the requirements of the sustained-release formulation.
结论成功制备了膜控型格列吡嗪缓释微丸，体外释放符合缓释制剂要求。
Conclusions The glipizide film-controlled sustained-release pellets were successfully prepared and the in-vitro drug release conformed to the requirements of the sustained-release formulation.
结论成功制备了膜控型格列吡嗪缓释微丸，体外释放符合缓释制剂要求。
应用推荐